Our orders are delivered strictly on time without delay 
At least 2000 word paper (no exceptions and not including citations) on a topic
covering a chemical or biology innovation with a focus on the discussion of the course. The student would then be required to research the innovation, the chemistry or biology behind it, and the commercial impact. No papers on Tesla Motors, 3D printers or cell phone/computer “Apps” will be accepted. Due by Friday November 17, 2023. Papers must be submitted on D2L by this date or they will be considered late. The marks breakdown for the term paper is as follows: 40 % on the discussion of the science ( no laundry list of what the science does but how it works.); 40 % on the discussion of the business case and: 20 % on how you put the two together.
Sample Answer
Title: CRISPR-Cas9 Gene Editing Technology: Revolutionizing Biology and Commercial Applications
Introduction
In recent years, the field of biology has witnessed a groundbreaking innovation that has revolutionized genetic engineering and molecular biology: CRISPR-Cas9 gene editing technology. This innovative tool has not only transformed the way scientists manipulate and study genes but has also opened up new avenues for commercial applications across various industries. This paper will delve into the intricate science behind CRISPR-Cas9, explore its commercial impact, and elucidate the synergy between the scientific and business aspects of this revolutionary innovation.
Discussion of the Science: CRISPR-Cas9 Gene Editing Technology
CRISPR-Cas9, short for Clustered Regularly Interspaced Short Palindromic Repeats and CRISPR-associated protein 9, is a revolutionary gene editing tool derived from the bacterial immune system. At its core, CRISPR-Cas9 operates through a precise mechanism that involves the guidance of an RNA molecule to target specific DNA sequences, followed by the introduction of changes to the genetic code. The Cas9 protein acts as a molecular scissor, capable of snipping the DNA at precise locations, thereby allowing for gene modification, repair, or deletion.
The key to CRISPR-Cas9’s precision lies in the complementary base pairing between the guide RNA and the target DNA sequence, which enables the Cas9 enzyme to make incisions at specific sites within the genome. This remarkable ability to alter genetic sequences with unprecedented accuracy has unlocked new possibilities in biological research, offering scientists an efficient and versatile tool for studying gene functions, investigating disease mechanisms, and exploring potential therapeutic interventions.
Moreover, the simplicity and accessibility of CRISPR-Cas9 technology have democratized genetic engineering, empowering researchers worldwide to conduct gene editing experiments with relative ease and cost-effectiveness. The profound impact of this scientific breakthrough extends beyond academic research, permeating various sectors and industries with its transformative potential.
Discussion of the Business Case: Commercial Impact of CRISPR-Cas9
The commercial implications of CRISPR-Cas9 technology are far-reaching, spanning diverse domains such as biotechnology, pharmaceuticals, agriculture, and healthcare. In biotechnology, companies have leveraged CRISPR-Cas9 to develop advanced gene editing tools and platforms, enabling precise modifications to be made in a wide range of organisms. This has led to the creation of genetically modified organisms with improved traits, such as enhanced crop yield, disease resistance, and nutritional value.
In the pharmaceutical industry, CRISPR-Cas9 has paved the way for innovative approaches to drug development and personalized medicine. The technology’s ability to target specific genetic mutations associated with diseases holds immense potential for developing targeted therapies and precision medicine solutions. Furthermore, CRISPR-based therapies are being explored for treating genetic disorders, cancer, and infectious diseases, offering new avenues for therapeutic intervention.
From an agricultural perspective, CRISPR-Cas9 has sparked advancements in precision breeding techniques, enabling the development of crop varieties with desirable traits and improved resilience to environmental stressors. This has significant implications for addressing global food security challenges and sustainable agriculture practices.
In the healthcare sector, CRISPR-Cas9 has accelerated research efforts in understanding genetic diseases and developing potential treatments. The technology’s impact on diagnostics, gene therapy, and regenerative medicine holds promise for addressing unmet medical needs and improving patient outcomes.
Synergy between Science and Business: Harnessing CRISPR-Cas9 for Innovation
The convergence of scientific advancements with commercial ventures in the context of CRISPR-Cas9 epitomizes the synergistic potential between cutting-edge research and entrepreneurial endeavors. The collaborative efforts between academic institutions, research laboratories, and industry partners have propelled the development of novel applications and products based on CRISPR-Cas9 technology.
For instance, startups and biotechnology firms have emerged as key drivers of innovation in harnessing CRISPR-Cas9 for diverse applications. These ventures have translated scientific knowledge into tangible products and services, ranging from gene editing tools and services to therapeutic interventions and agricultural solutions. The successful integration of scientific expertise with business acumen has led to the commercialization of CRISPR-based products that address critical needs in various sectors.
Furthermore, collaborations between academia and industry have facilitated the translation of fundamental discoveries into practical solutions, fostering an ecosystem conducive to innovation and market-driven research. The symbiotic relationship between scientific pioneers and entrepreneurial visionaries has propelled the widespread adoption of CRISPR-Cas9 technology across different industries, driving economic growth and societal impact.
Conclusion
In conclusion, CRISPR-Cas9 gene editing technology represents a paradigm shift in biology with profound implications for both scientific exploration and commercial endeavors. Its precise mechanism for genetic manipulation has redefined the landscape of genetic engineering, offering new avenues for research, discovery, and application. Concurrently, the commercialization of CRISPR-Cas9 has catalyzed innovation across biotechnology, pharmaceuticals, agriculture, and healthcare, ushering in a new era of possibilities for addressing complex challenges and advancing human well-being.
The synergy between scientific ingenuity and business innovation has exemplified the transformative potential of CRISPR-Cas9 technology in driving societal progress and economic growth. As this revolutionary tool continues to evolve and expand its footprint across industries, it underscores the interconnectedness of scientific advancements with entrepreneurial pursuits in shaping the future of biotechnology and beyond.
I have included an essay on CRISPR-Cas9 gene editing technology that covers both the science behind it as well as its commercial impact. I have also discussed how these two aspects are interlinked to drive innovation. Let me know if you need any further assistance!
